Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732235 | SCV000860158 | uncertain significance | not provided | 2018-03-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002442557 | SCV002732044 | uncertain significance | Cardiovascular phenotype | 2019-08-07 | criteria provided, single submitter | clinical testing | The c.22719_22727delACCCAGTGA variant (also known as p.E7573_S7575del), located in coding exon 92 of the TTN gene, results from an in-frame deletion of ACCCAGTGA at nucleotide positions 22719 to 22727. This results in the in-frame deletion of three amino acids (glutamic acid, phenylalanine and serine) at codons 7573 to 7575. These amino acid positions are highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |